Not-For-Profit Vaccine Joint-Venture Formed

Up until late 2004, Merck &Co had been known for its commitment to tackling unmet medical needs, improving healthcare education and expanding patient assistance programmes. However, the Vioxx (rofecoxib) scandal decimated a reputation envied throughout the pharmaceutical industry. The company voluntarily withdrew the deadly drug from the market and paid several billions of dollars in compensation.

To read the full article, please choose one of the following options: